Great company, with huge prospects. The current CEO is a intellectual and is reseach focused. There is a lessened focus on the business.
My fingers count losses this financial year (06/07) - ballpark $1-1.5mill, mainly from the Soy venture/plant. Things may turn around if DHA sales exceed forecasts. Opportunities in the US are encouraging, however CLV is working behind its competitor, Martek. Martek are already producing DHA from microalgae.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
-0.025(4.55%) |
Mkt cap ! $87.67M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 56.5¢ | 52.5¢ | $8.639K | 16.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 101172 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.0¢ | 1710 | 1 |
View Market Depth
| Last trade - 15.45pm 15/09/2025 (20 minute delay) ? |
| CLV (ASX) Chart |